Paoletti X, Lewsley LA, Daniele G, Cook A, Yanaihara N, Tinker A, Kristensen G, Ottevanger PB, Aravantinos G, Miller A, Boere IA, Fruscio R, Reyners AKL, Pujade-Lauraine E, Harkin A, Pignata S, Kagimura T, Welch S, Paul J, Karamouza E, Glasspool RM, Gynecologic Cancer InterGroup (GCIG) Meta-analysis Committee (2020)
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis
JAMA Netw Open, 3 (1), e1918939
DOI 10.1001/jamanetworkopen.2019.18939, PubMed 31922558

Multinu F, Ducie JA, Eriksson AGZ, Schlappe BA, Cliby WA, Glaser GE, Grassi T, Keeney GL, Weaver AL, Abu-Rustum NR, Leitao MM, Mariani A (2019)
Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: Comparison of comprehensive surgical staging and sentinel lymph node algorithm
Gynecol Oncol, 155 (2), 177-185
DOI 10.1016/j.ygyno.2019.09.011, PubMed 31604668

Roncolato F, Lindemann K, Willson ML, Martyn J, Mileshkin L (2019)
PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer
Cochrane Database Syst Rev (10), CD012160
DOI 10.1002/14651858.CD012160.pub2, PubMed 31588998